Inogen (INGN) stock
Members see every stock ranked and every check behind each score, live.
Why INGN scores -3
PoorTrending down, 2 of 14 checks firingWhat the Quality Score means
- +2Chart checks 2 of 14 firing right now, one point each
- −3Long-term trend below a falling 200-day average, down over one year, down over two years
- Size subtracts
- Profit subtracts
- Cash flow subtracts
- News adds
What's next
Expected to report Thu Nov 5, after the close
After its last 4 reports it closed -3.6% on average, higher 1 of 4 times.
What would turn INGN's score around: 7 things, for members
Here is what members see.
Every stock gets a card like this one, and a page with its price in real time, every line of its score, the chart, and its filings.
INGN has 2 of 14 checks firing
One per group is shown here.
How INGN ranks in Medical Devices
INGN is #71 of 75 by Quality Score. The top three are shown with their scores, and the rest by name.
DCTH7/1418
BLFS6/1418
HTFL9/1417
CBLLOpen for its score
HAEOpen for its score
INGN2/14-3
When does INGN report, and what happens after?
Expected to report Thu Nov 5, after the close (in 36 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 6, 2026After close | After close | -9.2% | -6.8% | -10.5% |
| May 7, 2026After close | After close | -0.3% | -2.4% | -5.4% |
| Feb 24, 2026After close | After close | -6.3% | +2.9% | +6.3% |
| Nov 5, 2025Before open | Before open | -0.5% | -8.3% | -13.3% |
About Inogen
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Every line of the score, on every stock.
- Real-time prices, no delay
- Every line of INGN's score, with the points and the reason
- All 14 checks on INGN and on all 2,953 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on INGN
Straight answers.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not for the first 24 hours. Tap any green button and you're in, with no email and no password. To keep going, create your account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.